Transcriptional profile of right ventricular tissue during acute pulmonary embolism in rats

Physiological Genomics

Volumn 34, Issue 1, 2008, Pages 101-111

  Zagorski, John ^a   Sanapareddy, Nina ^a   Gellar, Michael A ^a   Kline, Jeffrey A ^a   Watts, John A ^a  

^a CAROLINAS MEDICAL CENTER   (United States)

Author keywords

GeneSifter; Heart; Inflammation; Microarray; Pulmonary hypertension

Indexed keywords

CCL6 CHEMOKINE; CCL9 CHEMOKINE; CHEMOKINE; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CXCR4; CUTANEOUS T CELL ATTRACTING CHEMOKINE; CXCL1 CHEMOKINE; CXCL16 CHEMOKINE; CXCL2 CHEMOKINE; CXCL9 CHEMOKINE; FATTY ACID TRANSPORTER; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GLUCOSE TRANSPORTER; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 3; STROMAL CELL DERIVED FACTOR 1; THYMUS AND ACTIVATION REGULATED CHEMOKINE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA MICROARRAY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART RIGHT VENTRICLE FAILURE; INFLAMMATION; LUNG EMBOLISM; MALE; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RAT; REAL TIME POLYMERASE CHAIN REACTION; RECEPTOR UPREGULATION; UNINDEXED SEQUENCE; UPREGULATION; ACUTE DISEASE; ANIMAL; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HEART VENTRICLE; METABOLISM; PATHOLOGY; REPRODUCIBILITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPRAGUE DAWLEY RAT; TIME;

RATTUS;

ACUTE DISEASE; ANIMALS; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HEART VENTRICLES; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PULMONARY EMBOLISM; RATS; RATS, SPRAGUE-DAWLEY; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 47249160348     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00261.2007     Document Type: Article

References (43)

1. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-624, 2006.
2. Chu W, Burns DK, Swerlick RA, Presky DH. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J Biol Chem 270: 10236-10245, 1995.
3. 2 is reduced during hypotension and cardiac arrest in a rat model of massive pulmonary embolism. Resuscitation 53: 83-91, 2001.
4. Faber MJ, Dalinghaus M, Lankhuizen IM, Bezstarosti K, Verhoven AJM, Dunker DJ, Helbing WA, Lamers JMJ. Time dependent changes in cytoplasmic proteins of the right ventricle during prolonged pressure overload. J Mol Cell Cardiol 43: 197-209, 2007.
5. Fragasso G. Inhibition of free fatty acids metabolism as a therapeutic target in patients with heart failure. Int J Clin Pract 61: 603-610, 2007.
6. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part I: epidemiology, pathophysiology, and diagnosis. Circulation 108: 2726-2729, 2003.
7. Goldhaber SZ, Elliott CG. Acute pulmonary embolism: part II: risk stratification, treatment, and prevention. Circulation 108: 2834-2838, 2003.
8. Goldhaber SZ, Visani L, De Rosa M. Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353: 1386-1389, 1999.
9. Hirsh J, Hoak J. Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals. Circulation 93: 2212-2245, 1996.
10. Jones AE, Watts JA, Debelak JP, Thornton LR, Younger JD, Kline JA. Inhibition of prostaglandin synthesis during polystyrene microsphere-induced pulmonary embolism in the rat. Am J Physiol Lung Cell Mol Physiol 284: L1072-L1081, 2003.
11. Jung-Ching LJ, Gustafson-Wagner EA, Sinn HW, Choi S, Jaacks SM, Wang DZ, Evans S, Li-Chun LJ. Structure, expression and function of a novel intercalated disk protein, Xin. J Med Sci 25: 215-222, 2005.
12. Kasper W, Konstantinides S, Geibel A, Tiede N, Krause T, Just H. Prognostic significance of right ventricular after-load stress detected by echocardiography in patients with clinically suspected pulmonary embolism. Heart 77: 346-349, 1997.
13. Kemp TJ, Sadusky TJ, Saltisi F, Carey N, Moss J, Yang SY, Sassoon DA, Goldspink G, Coulton GR. Identification of Ankrd2, a novel skeletal muscle gene coding for a stretch-responsive ankyrin-repeat protein. Genomics 66: 229-241, 2000.
14. Kline JA, Maiorano PC, Schroeder JD, Grattan RM, Vary TC, Watts JA. Activation of pyruvate dehydrogenase improves heart function and metabolism after hemorrhagic shock. J Mol Cell Cardiol 29: 2465-2474, 1997.
15. Kline JA, Thornton LR, Lopaschuk GD, Barbee RW, Watts JA. Lactate improves cardiac efficiency after hemorrhagic shock. Shock 14: 215-221, 2000.
16. Kline JA, Hernandez-Nino J, Rose GA, Norton HJ, Camargo CA Jr. Surrogate markers for adverse outcomes in normotensive patients with pulmonary embolism. Crit Care Med 34: 2773-2780, 2006.
17. Kodde IF, van der Stok J, Smolenski RT, deJong JW. Metabolic and genetic regulation of cardiac energy substrate preference. Comp Biochem Physiol A 146: 26-39, 2007.
18. Kojic S, Medeot E, Guccione E, Krmac H, Zara I, Martinelli V, Valle G, Faulkner G. The ankrd2 protein, a link between the sarcomere and the nucleus in skeletal muscle. J Mol Biol 339: 313-325, 2004.
19. Kreit JW. The impact of right ventricular dysfunction on the prognosis and therapy of normotensive patients with pulmonary embolism. Chest 125: 1539-1545, 2004.
20. Lopaschuk GD. Regulation of carbohydrate metabolism in ischemia and reperfusion. Am Heart J 139: S115-S119, 2000.
21. Lopaschuk GD. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure. Semin Cardiothorac Vasc Anesth 10: 228-230, 2006.
22. Lualdi JC, Goldhaber SZ. Right ventricular dysfunction after acute pulmonary embolism: pathophysiologic factors, detection, and therapeutic implications. Am Heart J 130: 1276-1280, 1995.
23. 1-adrenergic activation of the cardiac ankyrin repeat protein gene in cardiac myocytes. Gene 297: 1-9, 2002.
24. Miller MK, Bang ML, Witt CC, Labeit D, Trombitas C, Watanabe K, Granzier H, McElhinny AS, Gregorio CC, Labeit S. The muscle ankyrin repeat domain proteins: CARP, ankrd2/Arpp and DARP as a family of titan filament-based stress response molecules. J Mol Biol 333: 951-964, 2003.
25. Moriyama M, Tsukamoto Y, Fugiwara M, Kondo G, Nakada C, Baba T, Ishiguro N, Miyazaki A, Nakamura K, Hori N, Sato K, Shomori K, Takeuchi K, Satoh H, Mori S, Ito H. Identification of a novel human ankyrin-repeated protein homologous to CARP. Biochem Biophys Res Commun 285: 715-723, 2001.
26. Neely JR, Morgan HE. Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Annu Rev Physiol 36: 413-459, 1974.
27. Pfaffl MW, Horgan GW, Dempfle L. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 30: e36, 2002.
28. Rajabi M, Kassiotis C, Razeghi P, Taegtmeyer H. Return to the fetal program protects the stressed heart: a strong hypothesis. Heart Fail Rev 12: 331-343, 2007.
29. Ribeiro A, Lindmarker P, Juhlin-Dannfelt A, Johnsson H, Jorfeldt L. Echocardiography Doppler in pulmonary embolism: right ventricular dysfunction as a predictor of mortality rate. Am Heart J 134: 479-487, 1997.
30. Ribeiro A, Lindmarker P, Johnsson H, Juhlin-Dannfelt A, Jorfeldt L. Pulmonary embolism: one-year follow-up with echocardiography Doppler and five-year survival analysis. Circulation 99: 1325-1330, 1999.
31. Sakanashi Y, Takeya M, Yoshimura T, Feng L, Morioka T, Takahashi T. Kinetics of macrophage subpopulations and expression of monocyte chemoattractant protein-1 (MCP-1) in bleomycin-induced lung injury of rats studied by a novel monoclonal antibody against rat MCP-1. J Leukoc Biol 56: 741-750, 1994.
32. Schoepf UJ, Kucher N, Kipfmueller F, Quiroz R, Costello P, Goldhaber SZ. Right ventricular enlargement on chest computed tomography: a predictor of early death in acute pulmonary embolism. Circulation 110: 3276-3280, 2004.
33. Sinn HW, Balsamo J, Lilien J, Lin JJ. Localization of the novel xin protein to the adherens junction complex in cardiac and skeletal muscle during development. Dev Dyn 225: 1-13, 2002.
34. Stevinson BG, Hernandez-Nino J, Rose G, Kline JA. Echocardiographic and functional cardiopulmonary problems 6 months after first-time pulmonary embolism in previously healthy patients. Eur Heart J 28: 2517-2524, 2007.
35. Tanaguchi M, Wilson C, Hunter CA, Pehowich DJ, Clanachan AS, Lopaschuk GD. Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. Am J Physiol Heart Circ Physiol 280: H1762-H1769, 2001.
36. Watts JA, Kline JA. Bench to bedside: the role of mitochondrial medicine in the pathogenesis and treatment of cellular injury. Acad Emerg Med 10: 985-997, 2003.
37. Watts JA, Zagorski J, Gellar MA, Stevinson BG, Kline JA. Cardiac inflammation contributes to right ventricular dysfunction following experimental pulmonary embolism in rats. J Mol Cell Cardiol 41: 296-307, 2006.
38. White RH. The epidemiology of venous thromboembolism. Circulation 107: 14-18, 2003.
39. Wood KE. Major pulmonary embolism: review of a pathophysiologic approach to the golden hour of hemodynamically significant pulmonary embolism. Chest 121: 877-905, 2002.
40. Zagorski J, Debelak J, Gellar M, Watts JA, Kline JA. Chemokines accumulate in the lungs of rats with severe pulmonary embolism induced by polystyrene microspheres. J Immunol 171: 5529-5536, 2003.
41. Zagorski J, Gellar MA, Obraztsova M, Kline JA, Watts JA. Inhibition of CINC-1 decreases right ventricular damage caused by experimental pulmonary embolism in rats. J Immunol 179: 7820-7826, 2007.
42. Zlotnik A, Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.
43. Zolk O, Frohme M, Maurer A, Kluxen FW, Hentsch B, Zubakov D, Hoheisel JD, Zucker IH, Pepe S, Eschenhagen T. Cardiac ankyrin repeat protein, a negative regulator of cardiac gene expression, is augmented in human heart failure. Biochem Biophys Res Commun 293: 1377-1382, 2002.